Press Releases and Events

PRESS RELEASES

Press Release | September 6, 2017

Crinetics Pharmaceuticals Awarded Two SBIR Grants to Develop New Therapeutics for Congenital Hyperinsulinism and Cushing’s Disease

READ MORE
Press Release | July 13, 2017

Crinetics Pharmaceuticals Awarded $2.8 Million SBIR Grant to Support Development of Acromegaly Drug Candidate CRN00808

READ MORE
Press Release | November 10, 2016

Crinetics Pharmaceuticals Appoints Anne Klibanski, M.D. to Scientific Advisory Board

READ MORE
Press Release | June 6, 2016

Crinetics Pharmaceuticals Appoints Ajay Madan as Vice President, Development

READ MORE
Press Release | November 2, 2015

The San Diego Union-Tribune: Crinetics raises $40 Million

READ MORE
Press Release | November 2, 2015

Crinetics Pharmaceuticals Completes $40 Million Series A Financing

READ MORE
Press Release | April 27, 2015

Crinetics Pharmaceuticals Appoints Matt Fust, M.B.A., David Clemons, M.D., and John Wallen, Ph.D., J.D. as Corporate, Clinical, and Legal Advisers

READ MORE
Press Release | April 27, 2015

Crinetics Pharmaceuticals Awarded NIH Fast-Track Grant to Develop Somatostatin Receptor Agonist Drugs for Chronic Pain

READ MORE
Press Release | January 28, 2015

Crinetics Pharmaceuticals Awarded $1.5MM NIH Phase-II SBIR Grant to Develop Kisspeptin Receptor Antagonists for PCOS and Other Women’s Health Diseases

READ MORE
Press Release | April 28, 2014

Crinetics Pharmaceuticals Awarded NIH Phase-I SBIR Grant to Develop Somatostatin Receptor Agonist Drugs for Ophthalmic Diseases

READ MORE
24 / 25